Abiopharma

News list

(99% Neutral) TALARIS THERAPEUTICS, INC. (TALS) Announces Clinical Development Update

Full text

News bot Oct. 1, 2025, 8:37 p.m.
📋 TALARIS THERAPEUTICS, INC. (TALS) - Clinical Trial Update

Filing Date: 2022-05-17

Accepted: 2022-05-17 08:29:03

Event Type: Clinical Trial Update
Event Details:
Talaris Therapeutics Inc (TALS) Announces Clinical Trial Update Talaris Therapeutics Inc (TALS) provided an update on its clinical development programs. Clinical Development Highlights:
Diseases/Conditions: Australia
Clinical Stage: clinical trial
Collaboration: the Chief Medical Officer
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Talaris Therapeutics Inc
- CIK: 0001827506
- Ticker Symbol: TALS
- Period End Date: 2022-05-13
- Document Type: 8-K